# Can Airflow Limitation in Chronic Obstructive Pulmonary Disease (COPD) be Reversible by Drugs?

> **NCT01010178** · PHASE4 · COMPLETED · sponsor: **Baqiyatallah Medical Sciences University** · enrollment: 64 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Macrolid, Theophylline, Inhaler Corticosteroids

## Key facts

- **NCT ID:** NCT01010178
- **Lead sponsor:** Baqiyatallah Medical Sciences University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-04
- **Final completion:** 2009-07
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2009-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01010178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01010178, "Can Airflow Limitation in Chronic Obstructive Pulmonary Disease (COPD) be Reversible by Drugs?". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01010178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*